Summary
- Current Price
- As of today, ANRO price is $20.02, down -6.75% on
- Current Price All-Time High
- ANRO price is currently -20.46% below its historical high of $25.17 set on
- Market Cap
- ANRO current market cap is $622M, up +766.93% over the past 365 days
- PE Ratio
- ANRO PE ratio is unknown
- Revenue
- ANRO current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for ANRO is on
Profile
| Metric | Value |
|---|---|
| Full Name | Alto Neuroscience, Inc. |
| Ticker | NYSE: ANRO |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | altoneuroscience.com |
| Employees | 76 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $20.02 | |
| Price, 1D Change | -6.75% | |
| $622M | ||
| - | ||
| - | ||
| 1.15 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.19 | ||
| EPS, 1Y Change | +12.22% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.19 | ||
| EPS Estimate | N/A | -$2.10 |
| EPS Est. Change | N/A | +4.19% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $20.02 | |
| Price Target | - | $34.00 |
| Price Tgt. Change | - | +69.83% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.60 | -$2.50 | +3.84% | |
| -$2.25 | -$2.19 | +2.54% | |
| -$2.10 | N/A | +4.19% | |
| -$2.28 | N/A | -3.80% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $20.02 | |
| $10.32 | ||
| SMA 200 vs Price | -48.43% | |
| $18.52 | ||
| SMA 50 vs Price | -7.51% | |
| 1.15 | ||
| $1.88 | ||
| 48.01 | ||
| 98.31% | ||
| 131.36% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$2.19 | ||
| -$661.00K | ||
| - | ||
| -$66.36M | ||
| - | ||
| -$63.24M | ||
| - | ||
| -$65.70M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.16 | ||
| 15.69 | ||
| 15.69 | ||
| - | ||
| - | ||
| 9.49 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 4.11 | ||
| -7.14 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $151.14M | ||
| $176.48M | ||
| $184.69M | ||
| $177.72M | ||
| $33.55M | ||
| $11.33M | ||
| $23.96M | ||
| $1.74M | ||
| $1.88M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $63.24M | ||
| $65.70M | ||
| $661.00K | ||
| $0.00 | ||
| $661.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$51.77M | ||
| -$24.00K | ||
| $60.08M | ||
| $24.00K | ||
| -$51.79M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Baird | → | |
| Wedbush | → | |
| Chardan Capital | → | |
| BTIG | → | |
| Chardan Capital | → | |
| BTIG | ||
| Baird | → | |
| Jefferies | → | |
| HC Wainwright & Co. | → | |
| Baird | → |
Analyst sentiment
Institutional ownership
Screeners with ANRO
FAQ
What is the ticker symbol for Alto Neuroscience, Inc.?
The ticker symbol for Alto Neuroscience, Inc. is NYSE:ANRO
Does Alto Neuroscience, Inc. pay dividends?
No, Alto Neuroscience, Inc. does not pay dividends
What sector is Alto Neuroscience, Inc. in?
Alto Neuroscience, Inc. is in the Healthcare sector
What industry is Alto Neuroscience, Inc. in?
Alto Neuroscience, Inc. is in the Biotechnology industry
What country is Alto Neuroscience, Inc. based in?
Alto Neuroscience, Inc. is headquartered in United States
When did Alto Neuroscience, Inc. go public?
Alto Neuroscience, Inc. initial public offering (IPO) was on February 2, 2024
Is Alto Neuroscience, Inc. in the S&P 500?
No, Alto Neuroscience, Inc. is not included in the S&P 500 index
Is Alto Neuroscience, Inc. in the NASDAQ 100?
No, Alto Neuroscience, Inc. is not included in the NASDAQ 100 index
Is Alto Neuroscience, Inc. in the Dow Jones?
No, Alto Neuroscience, Inc. is not included in the Dow Jones index
When was Alto Neuroscience, Inc. last earnings report?
Alto Neuroscience, Inc.'s most recent earnings report was on November 12, 2025
When does Alto Neuroscience, Inc. report earnings?
The next expected earnings date for Alto Neuroscience, Inc. is May 14, 2026
Data Sources & References
- ANRO Official Website www.altoneuroscience.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1999480/000199948026000002/0001999480-26-000002-index.htm
- ANRO Profile on Yahoo Finance finance.yahoo.com/quote/ANRO
- ANRO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/anro